Crizotinib is an inhibitor of anaplastic lymphoma kinase (ALK) andc-MET.Recently, rearrangements involving theALKgene were discovered in rare, poorly differentiated, and anaplastic thyroid cancers and, more frequently, in radiation-induced DTC (48,49). Here, ALK is linked to thyroid gland undifferentiated (anaplastic) carcinoma.